255 — Lung Kee group Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$707.48m
- HK$241.41m
- HK$1.45bn
- 64
- 77
- 11
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 192 | 221 | 315 | 21.7 | -113 |
Depreciation | |||||
Non-Cash Items | -26.4 | -0.786 | -11 | -33.7 | -6.14 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6.88 | -11.4 | -107 | -69.8 | 26.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 332 | 355 | 354 | 76.9 | 77.2 |
Capital Expenditures | -82.7 | -113 | -201 | -182 | -113 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 25.5 | 18.9 | 24.5 | 24.6 | 14.9 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -57.2 | -94.2 | -177 | -158 | -98.1 |
Financing Cash Flow Items | -0.423 | -0.509 | -0.455 | -0.363 | -0.406 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -152 | -139 | -278 | -169 | -73.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 108 | 165 | -85 | -297 | -108 |